These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33043416)

  • 1. Platelet microvesicles are associated with the severity of coronary artery disease: comparison between peripheral and coronary circulation.
    Gkaliagkousi E; Gavriilaki E; Yiannaki E; Vasileiadis I; Nikolaidou B; Lazaridis A; Dolgyras P; Grigoriadis S; Triantafyllou A; Anyfanti P; Markala D; Zarifis I; Douma S
    J Thromb Thrombolysis; 2021 May; 51(4):1138-1143. PubMed ID: 33043416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial Microvesicles Circulating in Peripheral and Coronary Circulation Are Associated With Central Blood Pressure in Coronary Artery Disease.
    Gkaliagkousi E; Gavriilaki E; Vasileiadis I; Nikolaidou B; Yiannaki E; Lazaridis A; Triantafyllou A; Anyfanti P; Markala D; Zarifis I; Douma S
    Am J Hypertens; 2019 Nov; 32(12):1199-1205. PubMed ID: 31350539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome.
    Kafian S; Mobarrez F; Wallén H; Samad B
    Platelets; 2015; 26(5):467-73. PubMed ID: 25025694
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Nijiati M; Saidaming A; Guoqing L
    Ann Clin Lab Sci; 2017 Mar; 47(2):156-161. PubMed ID: 28442516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y
    Chyrchel B; Drożdż A; Długosz D; Stępień EŁ; Surdacki A
    Int J Med Sci; 2019; 16(2):264-275. PubMed ID: 30745807
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent circulating platelet and endothelial derived microparticle signature may explain on-going pro-thrombogenicity after acute coronary syndrome.
    Koganti S; Eleftheriou D; Gurung R; Hong Y; Brogan P; Rakhit RD
    Thromb Res; 2021 Oct; 206():60-65. PubMed ID: 34418680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of platelet-derived microvesicles and their phenotypes with carotid atherosclerosis and recurrent vascular events in patients after ischemic stroke.
    Rosińska J; Ambrosius W; Maciejewska J; Narożny R; Kozubski W; Łukasik M
    Thromb Res; 2019 Apr; 176():18-26. PubMed ID: 30763823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived microvesicles activate human platelets via intracellular calcium mediated reactive oxygen species release.
    Yadav P; Beura SK; Panigrahi AR; Bhardwaj T; Giri R; Singh SK
    Blood Cells Mol Dis; 2023 Jan; 98():102701. PubMed ID: 36057195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis.
    Badimon L; Suades R; Fuentes E; Palomo I; Padró T
    Front Pharmacol; 2016; 7():293. PubMed ID: 27630570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute coronary syndrome is associated with a substantial change in the platelet lipidome.
    Harm T; Bild A; Dittrich K; Goldschmied A; Nestele J; Chatterjee M; Fu X; Kolb K; Castor T; Borst O; Geisler T; Rath D; LäMmerhofer M; Gawaz M
    Cardiovasc Res; 2022 Jun; 118(8):1904-1916. PubMed ID: 34323932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived microvesicles (PMVs) in cancer progression and clinical applications.
    Pan Y; Wang Y; Wang Y; Xu S; Jiang F; Han Y; Hu M; Liu Z
    Clin Transl Oncol; 2023 Apr; 25(4):873-881. PubMed ID: 36417084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growing thrombi release increased levels of CD235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients.
    Suades R; Padró T; Vilahur G; Martin-Yuste V; Sabaté M; Sans-Roselló J; Sionis A; Badimon L
    J Thromb Haemost; 2015 Oct; 13(10):1776-86. PubMed ID: 26239059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-Derived Microvesicles in Cardiovascular Diseases.
    Zaldivia MTK; McFadyen JD; Lim B; Wang X; Peter K
    Front Cardiovasc Med; 2017; 4():74. PubMed ID: 29209618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery.
    Rath D; Chatterjee M; Borst O; Müller K; Stellos K; Mack AF; Bongartz A; Bigalke B; Langer H; Schwab M; Gawaz M; Geisler T
    Eur Heart J; 2014 Feb; 35(6):386-94. PubMed ID: 24168792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Mean Platelet Volume to Predict Significant Coronary Artery Disease in Patients With Non-ST-Elevation Acute Coronary Syndromes.
    Taskesen T; Sekhon H; Wroblewski I; Goldfarb M; Ahmad MB; Nguyen QT; Fughhi IA; Gidron A; Dadkhah S
    Am J Cardiol; 2017 Jan; 119(2):192-196. PubMed ID: 27814786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvesicles from patients with acute coronary syndrome enhance platelet aggregation.
    Kafian S; Wallén H; Samad BA; Mobarrez F
    Scand J Clin Lab Invest; 2019 Nov; 79(7):507-512. PubMed ID: 31502883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.
    Müller II; Müller KA; Karathanos A; Schönleber H; Rath D; Vogel S; Chatterjee M; Schmid M; Haas M; Seizer P; Langer H; Schaeffeler E; Schwab M; Gawaz M; Geisler T
    Atherosclerosis; 2014 Dec; 237(2):426-32. PubMed ID: 25463068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived microvesicles promote endothelial progenitor cell proliferation in intimal injury by delivering TGF-β1.
    Yan J; Bao H; Fan YJ; Jiang ZL; Qi YX; Han Y
    FEBS J; 2020 Dec; 287(23):5196-5217. PubMed ID: 32167224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
    Idriss NK; Lip GY; Balakrishnan B; Jaumdally R; Boos CJ; Blann AD
    Thromb Haemost; 2010 Nov; 104(5):1029-37. PubMed ID: 20838751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares and cardiovascular comorbidities.
    Anyfanti P; Gavriilaki E; Nikolaidou B; Yiannaki E; Lazaridis A; Papadopoulos N; Douma S; Doumas M; Gkaliagkousi E
    J Thromb Thrombolysis; 2022 Jan; 53(1):10-16. PubMed ID: 34224067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.